Distinct expression of functionally glycosylated alpha-dystroglycan in muscle and non-muscle tissues of FKRP mutant mice

The glycosylation of alpha-dystroglycan (α-DG) is crucial in maintaining muscle cell membrane integrity. Dystroglycanopathies are identified by the loss of this glycosylation leading to a breakdown of muscle cell membrane integrity and eventual degeneration. However, a small portion of fibers expressing functionally glycosylated α-DG (F-α-DG) (revertant fibers, RF) have been identified. These fibers are generally small in size, centrally nucleated and linked to regenerating fibers. Examination of different muscles have shown various levels of RFs but it is unclear the extent of which they are present. Here we do a body-wide examination of muscles from the FKRP-P448L mutant mouse for the prevalence of RFs. We have identified great variation in the distribution of RF in different muscles and tissues. Triceps shows a large increase in RFs and together with centrally nucleated fibers whereas the pectoralis shows a reduction in revertant but increase in centrally nucleated fibers from 6 weeks to 6 months of age. We have also identified that the sciatic nerve with near normal levels of F-α-DG in the P448Lneo- mouse with reduced levels in the P448Lneo+ and absent in LARGEmyd. The salivary gland of LARGEmyd mice expresses high levels of F-α-DG. Interestingly the same glands in the P448Lneo-and to a lesser degree in P448Lneo+ also maintain considerable amount of F-α-DG, indicating the non-proliferating epithelial cells have a molecular setting permitting glycosylation.

[1]  Bo Wu,et al.  Restoration of Functional Glycosylation of α-Dystroglycan in FKRP Mutant Mice Is Associated with Muscle Regeneration. , 2015, The American journal of pathology.

[2]  Bo Wu,et al.  Dystroglycanopathy muscles lacking functional glycosylation of alpha-dystroglycan retain regeneration capacity , 2015, Neuromuscular Disorders.

[3]  J. Carette,et al.  Deciphering the Glycosylome of Dystroglycanopathies Using Haploid Screens for Lassa Virus Entry , 2013, Science.

[4]  Xiao Xiao,et al.  Mouse models of fukutin-related protein mutations show a wide range of disease phenotypes , 2013, Human Genetics.

[5]  M. Hurles,et al.  Mutations in B3GALNT2 cause congenital muscular dystrophy and hypoglycosylation of α-dystroglycan. , 2013, American journal of human genetics.

[6]  W. Halliday,et al.  Missense mutations in β-1,3-N-acetylglucosaminyltransferase 1 (B3GNT1) cause Walker–Warburg syndrome , 2013, Human molecular genetics.

[7]  C. Fallet-Bianco,et al.  Identification of mutations in TMEM5 and ISPD as a cause of severe cobblestone lissencephaly. , 2012, American journal of human genetics.

[8]  S. Gabriel,et al.  Exome sequencing and functional validation in zebrafish identify GTDC2 mutations as a cause of Walker-Warburg syndrome. , 2012, American journal of human genetics.

[9]  Francesco Muntoni,et al.  ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome , 2012, Nature Genetics.

[10]  J. Vissing,et al.  Level of muscle regeneration in limb-girdle muscular dystrophy type 2I relates to genotype and clinical severity , 2011, Skeletal Muscle.

[11]  H. Lidov,et al.  Fukutin-related protein is essential for mouse muscle, brain and eye development and mutation recapitulates the wide clinical spectrums of dystroglycanopathies. , 2010, Human molecular genetics.

[12]  Susan C. Brown,et al.  A Comparative Study of α‐Dystroglycan Glycosylation in Dystroglycanopathies Suggests that the Hypoglycosylation of α‐Dystroglycan Does Not Consistently Correlate with Clinical Severity , 2009, Brain pathology.

[13]  Takashi Fujikado,et al.  Pikachurin, a dystroglycan ligand, is essential for photoreceptor ribbon synapse formation , 2008, Nature Neuroscience.

[14]  Paul T Martin,et al.  Congenital muscular dystrophies involving the O-mannose pathway. , 2007, Current molecular medicine.

[15]  K. Matsumura,et al.  Defective peripheral nerve myelination and neuromuscular junction formation in fukutin‐deficient chimeric mice , 2007, Journal of neurochemistry.

[16]  J. Hewitt,et al.  Characterization of the LARGE family of putative glycosyltransferases associated with dystroglycanopathies. , 2005, Glycobiology.

[17]  M. Huynen,et al.  POMT2 mutations cause α-dystroglycan hypoglycosylation and Walker-Warburg syndrome , 2005, Journal of Medical Genetics.

[18]  N. Nakanishi,et al.  LARGE2 facilitates the maturation of α-dystroglycan more effectively than LARGE , 2005 .

[19]  E. Levedakou,et al.  Disruption of the mouse Large gene in the enr and myd mutants results in nerve, muscle, and neuromuscular junction defects , 2005, Molecular and Cellular Neuroscience.

[20]  M. Mizuguchi,et al.  Fukutin expression in mouse non-muscle somatic organs: its relationship to the hypoglycosylation of α-dystroglycan in Fukuyama-type congenital muscular dystrophy , 2004, Brain and Development.

[21]  Susan C. Brown,et al.  Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan. , 2003, Human molecular genetics.

[22]  C. Walsh,et al.  Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome. , 2002, American journal of human genetics.

[23]  J. Mendell,et al.  Disruption of Dag1 in Differentiated Skeletal Muscle Reveals a Role for Dystroglycan in Muscle Regeneration , 2002, Cell.

[24]  Susan C. Brown,et al.  Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan. , 2001, American journal of human genetics.

[25]  K. Campbell,et al.  Dystroglycan binding to laminin alpha1LG4 module influences epithelial morphogenesis of salivary gland and lung in vitro. , 2001, Differentiation; research in biological diversity.

[26]  Susan C. Brown,et al.  Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. , 2001, Human molecular genetics.

[27]  M. Mizuno,et al.  Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. , 2001, Developmental cell.

[28]  T. Südhof,et al.  A stoichiometric complex of neurexins and dystroglycan in brain , 2001, The Journal of cell biology.

[29]  S. Carbonetto,et al.  α-Dystroglycan Is a Laminin Receptor Involved in Extracellular Matrix Assembly on Myotubes and Muscle Cell Viability , 1999, The Journal of cell biology.

[30]  R. Timpl,et al.  Binding of the G domains of laminin α1 and α2 chains and perlecan to heparin, sulfatides, α‐dystroglycan and several extracellular matrix proteins , 1999 .

[31]  K. Campbell,et al.  Dystrophic phenotype induced in vitro by antibody blockade of muscle alpha-dystroglycan-laminin interaction. , 1999, Journal of cell science.

[32]  I. Kanazawa,et al.  An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy , 1998, Nature.

[33]  K. Campbell,et al.  Distribution of Dystroglycan in Normal Adult Mouse Tissues , 1998, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[34]  K. Campbell,et al.  A role for dystrophin-associated glycoproteins and utrophin in agrin-induced AChR clustering , 1994, Cell.

[35]  S. Carbonetto,et al.  Dystroglycan-α, a dystrophin-associated glycoprotein, is a functional agrin receptor , 1994, Cell.

[36]  K. Campbell,et al.  Differential expression of dystrophin, utrophin and dystrophin‐associated proteins in peripheral nerve , 1993, FEBS letters.

[37]  M. Grounds,et al.  Age-related changes in replication of myogenic cells in mdx mice: Quantitative autoradiographic studies , 1993, Journal of the Neurological Sciences.

[38]  G. Butler-Browne,et al.  Expression of myosin isoforms during notexin-induced regeneration of rat soleus muscles. , 1990, Developmental biology.

[39]  D. Shotton,et al.  Muscular dystrophy in the mdx mouse: Histopathology of the soleus and extensor digitorum longus muscles , 1987, Journal of the Neurological Sciences.

[40]  N. Nakanishi,et al.  LARGE2 facilitates the maturation of alpha-dystroglycan more effectively than LARGE. , 2005, Biochemical and biophysical research communications.

[41]  Denis Bernabé,et al.  POMT2 mutations cause alpha-dystroglycan hypoglycosylation and Walker-Warburg syndrome , 2005 .

[42]  R. Timpl,et al.  Binding of the G domains of laminin alpha1 and alpha2 chains and perlecan to heparin, sulfatides, alpha-dystroglycan and several extracellular matrix proteins. , 1999, The EMBO journal.

[43]  S. Carbonetto,et al.  Dystroglycan-alpha, a dystrophin-associated glycoprotein, is a functional agrin receptor. , 1994, Cell.